Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Lisa M. Blanchette"'
Publikováno v:
Infectious Diseases in Clinical Practice. 30:1-4
Autor:
Mary Ghaffari, Martina Powell, Lisa M. Blanchette, Aaron Steffenhagen, James Terenyi, Jacob Holler, Niyati Vakil
Publikováno v:
Journal of the American Pharmacists Association : JAPhA. 61(6)
The continued advancement of pharmacy practice demands highly skilled and knowledgeable pharmacy technicians to enhance the services provided. As technician responsibilities continue to evolve to include more advanced roles, the need for standardized
Autor:
Katie J. Suda, Lisa M. Blanchette, Wenjing Wei, Michael E. Klepser, Timothy P. Gauthier, Karl Madaras Kelly, Michael D Nailor, Emily L. Heil
Publikováno v:
Journal of the American Pharmacists Association. 58:481-484
Objectives The objective of this position statement is to describe the essential role of pharmacists in antimicrobial stewardship in outpatient care. Data sources N/A. Summary The majority of antibiotic prescribing occurs in outpatient care settings
Publikováno v:
Therapeutic Advances in Infectious Disease. 5:57-62
Traditional metronidazole dosing regimens utilize an every 8 h dosing strategy to treat anaerobic and mixed anaerobic infections. However, pharmacokinetic data demonstrate that the half-life of metronidazole is 8–12 h and blood levels at 12 h excee
Publikováno v:
Scandinavian Journal of Infectious Diseases. 46:803-808
There are no comparative data evaluating outcomes of ertapenem treatment for infections with AmpC-producing Enterobacteriaceae. This retrospective matched case-control study was conducted between 2009 and 2012. Sixteen cases treated with ertapenem we
Publikováno v:
American Journal of Health-System Pharmacy. 71:114-121
Purpose Results of a study comparing clinical and cost outcomes with the use of standardized versus custom-prepared parenteral nutrition (PN) in an acute care setting are reported. Methods In a retrospective pre–post analysis, nutritional target at
Autor:
Lisa M. Blanchette, Michael D. Gooch, Jacinta Chin, Sarah Green, David H. Priest, Lacie McKamey
Publikováno v:
Open Forum Infectious Diseases
Background Optimal use of fluoroquinolones (FQ) is a common antimicrobial stewardship program (ASP) target based on well-cited risk for Clostridium difficile colitis and has gained national attention in the setting of recent FDA warnings about seriou
Publikováno v:
Open Forum Infectious Diseases. 2
Overuse and inappropriate use of antimicrobials in the ambulatory setting may promote resistance and adverse events including C. difficile infection and significant side effects/allergic reactions. Limited work has been done in office-based practices
Autor:
Blanchette LM; Lisa M. Blanchette, Pharm.D., is Infectious Diseases Clinical Pharmacy Specialist, Novant Health Presbyterian Medical Center, Charlotte, NC. Paul Huiras, Pharm.D., BCPS, is Surgical Intensive Care Unit Clinical Pharmacy Specialist; and Stella Papadopoulos, Pharm.D., BCPS, is Administrative Director, Clinical and Academic Affairs, Boston Medical Center, Boston, MA., Huiras P, Papadopoulos S
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2014 Jan 15; Vol. 71 (2), pp. 114-21.